Abstract
The present work reports photocatalytic degradation of cetirizine hydrochloride (CTZ-HCl) utilizing polypyrrole (PPy) nanohybrids with ZnFe2O4 (ZnFe) nanoparticles. The synthesized materials were characterized using UV-visible spectroscopy, X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), photoluminescence (PL) spectroscopy, BET, and scanning electron microscopy (SEM) techniques. UV diffuse reflectance studies (UV-DRS) revealed that the band gap was found to decrease with increase in the loading of PPy and Kubelka-Munk plots confirmed the bandgap values to be 2.14eV for ZnFe, 1.94eV for 1% PPy/ZnFe, 1.66eV for 3% PPy/ZnFe, and 1.38eV for 5% PPy/ZnFe. The photocatalytic performance against CTZ-HCl degradation was performed under visible light irradiation for 60min. The effect of catalyst dosage and the effect of drug concentration were investigated to confirm degradation behavior of the PPy/ZnFe photocatalysts. The degradation followed the pseudo-first-order kinetics model. Maximum photocatalytic degradation was observed to be 98% within 60min using 5% PPy/ZnFe as the photocatalyst. The recyclability tests revealed that the 5% PPy/ZnFe photocatalyst was reusable up to 4 cycles. Radical scavenging studies confirmed the generation of ●OH radicals that were responsible for the drug degradation. The degraded fragments were analyzed using LCMS technique and the tentative mechanism of degradation was proposed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Environmental science and pollution research international
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.